Repligen
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 months.
- Recent price momentum is -1.5% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 11.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation F
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 155.0x | Better than 2% |
| Price / Sales | 13.3x | Better than 8% |
Growth C
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -2.7% | Better than 16% |
| Net income CAGR (3Y) | -35.9% | Better than 9% |
| Free cash flow CAGR (3Y) | 33.3% | Better than 76% |
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 52.3% | Better than 65% |
| Operating margin | 5.6% | Better than 37% |
| Net margin | 6.6% | Better than 49% |
| Return on equity | 2.4% | Better than 31% |
| Return on invested capital | 2.4% | Better than 35% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -9.6% | Better than 52% |
| 6-month return | 42.4% | Better than 94% |
| 12-month return (ex latest month) | 8.9% | Better than 45% |
| Distance below 52-week high | 17.6% | Better than 66% |
Financial Health A-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 8.4x | Better than 92% |
| Debt to assets | 23.4% | Better than 51% |
| Interest coverage | 3.9x | Better than 50% |
| Free cash flow / net income | 187.5% | Better than 74% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 87.5% | Better than 69% |
| Upside to average target | 28.4% | Better than 46% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 170.29
- Open
- 169.61
- Day range
- 162.47 - 169.61
- Avg price
- 165.31
- Volume
- 697.70K
- Turnover
- 115.34M
- Turnover ratei
- 1.14%
- Volume ratioi
- 0.86
- Amplitudei
- 4.20%
- 52-week rangei
- 100.99 - 198.87
Valuation
- P/Ei
- 190.48
- P/E (TTM)i
- -780.05
- P/Bi
- 5.01
- EPSi
- 0.86
- Book value / shi
- 32.72
- Net profit
- 54.97M
- Net assets
- 2.09B
Share structure
- Market cap
- 10.47B
- Float capi
- 9.99B
- Shares out
- 63.92M
- Float sharesi
- 60.96M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
17.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+20.08M net over the window
Short interest
- Shares short
- 7.05M
- % of floati
- 11.11%
- Days to coveri
- 4.87
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Repligen (RGEN)?
Repligen last traded at 163.81. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Repligen's market cap?
About 10.47B.
What is the P/E ratio of Repligen?
The trailing twelve-month P/E is -780.05, below its own 5-year average of 111.31 — toward the bottom of its historical range (12.20% percentile). See the Valuation tab for the full history.
Does Repligen pay a dividend?
Repligen does not currently pay a regular dividend.
Is Repligen a buy according to analysts?
The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 210.29, which implies 28.4% upside from the current price. This is not investment advice.
What is Repligen's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Repligen a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Repligen discussion 0 comments